Management team
Peter Reiss
Director
Peter Reiss has been Director of the Netherlands HIV Monitoring Foundation since 2013. He serves on the Scientific Advisory Boards of the Agence Nationale de Recherches sur le Sida et les hépatites virales (ANRS) and the Swiss HIV Cohort Study. He has been a member of the Steering Committees of the D:A:D study, the Antiretroviral Therapy Cohort Collaboration and the EuroSida Study, and one of the four rotating scientific coordinators of EuroCoord. He also is a member of the UNAIDS Scientific Expert Panel and Strategic and Technical Advisory Committee, advising the UNAIDS Executive Director.
Dr. Reiss is clinical HIV section editor for Antiviral Therapy and editorial board member of a number of several other journals. He has served as President of the European Aids Clinical Society (EACS) from 2008-2012 and currently is a member of EACS’s Governing Board. From 2006-2014 he served on the Governing Council of the International AIDS Society (IAS). He currently serves as co-chair of the 22nd International AIDS Conference, AIDS 2018, scheduled for July 2018 in Amsterdam. His research focuses primarily on the complications of HIV and HIV treatment, and more particularly in relation to ageing
Sima Zaheri
Deputy director
On behalf of the director, she is responsible for the day-to-day implementation of this strategy in terms of data & QC, human resource management, finance and control, and organisation and data security, and drives various organization-wide operational management processes. Sima works closely with the HIV-treating physicians, researchers, nurse consultants and others who use SHM’s data in the 26 HIV treatment centres in the Netherlands to ensure that important developments in the HIV and AIDS field are translated into processes, and to monitor the quality and efficiency of these processes on an ongoing basis. Within this context, Sima has managed several innovation and improvement projects.
Ard van Sighem
Senior Researcher
He is also interested in the more patient-specific side of the HIV epidemic. In particular, Ard is collaborating with cohorts from other countries to investigate changes in causes of death in people living with HIV.
Lastly, Ard works together with the European Centre for Disease Control and Prevention to estimate the size of the population of people living with HIV, including those as yet undiagnosed, in Europe, and on nationwide and regional levels.